Establishment of Antisense Therapy for Hematological Mailg-nancies Targeted Their Rearranged Genes.
Establishment of Antisense Therapy for Hematological Mailg-nancies Targeted Their Rearranged Genes.
批准号:
09671094
负责人:
MAEKAWA Taira
金额:
$2.3万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1998
中文摘要
在本研究项目中,我们阐明了反义寡脱氧核苷酸(AS ODN)对重排和过表达癌基因抑制人白血病细胞增殖的机制。1) BCR-ABL AS ODN可通过诱导慢性髓系白血病(CML)细胞凋亡,有效抑制CML细胞的增殖。c-myc AS ODN能抑制人白血病细胞hl60的增殖,使G_1/S交界区白血病细胞数量突变上调。c-myc AS ODN还通过Fas/Fas配体系统抑制类风湿关节炎滑膜细胞的增殖并诱导细胞凋亡。2)建立了具有硫代磷和二酯键嵌合骨架结构的AS ODN的合成和纯化方法。5′端和3′端的前三个键都是通过硫代化学合成的。我们已经证明这些嵌合类似物能够抵抗核酸酶的降解。3)上述嵌合类似物具有更少的非特异性效应或适体效应,而当使用具有全硫代键的AS odn时,通常会遇到这种效应。4)我们已经发现,具有嵌合骨架的AS odn可以有效地对抗Bcl-2、c-myc、促红细胞生成素受体和基质衍生因子1,并且我们发现了新的靶向反义序列来降低Bcl-2的表达。
英文摘要
In this research project, we have clarified followings concerning the mechanism of suppression of the proliferation of human leukemic cells by antisense oligodeoxynucleotides (AS ODN) for rearranged and over-expressed oncogenes.1) BCR-ABL AS ODN could effectively suppress the proliferation of chronic myeloid leukemia (CML) cells by the induction of apoptosis of these leukemia cells. c-myc AS ODN could inhibit the proliferation of human leukemia cells HL6O, and the abrupt up-regulation of number of leukemia cells in G_1/S boundary. c-myc AS ODN also inhibited the proliferation of synovial cells from patients with rheumatoid arthritits and induced the apoptosis through Fas/Fas ligand system.2) We have established the synthesis and purification methods of AS ODN with chimeric backbone structure of phosphorothioate and phosphodiester linkages. The first three linkages of both 5'- and 3'-end are synthesized by phosphorothioate chemistry. We have shown these chimeric analogues were resistant to the degradation by nuclease.3) The above chimeric analogue have much less non-specific effects or aptamer effects that are often encountered when AS ODNs with all-phosphorothioate linkages are used.4) We have shown that AS ODNs with chimeric backbones against Bcl-2, c-myc, erythropoietin receptor, and stromal-derived factor 1 effectively work as functional antisense molecules, and we have found the novel target antisense sequence to reduce the Bcl-2 expression.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
前川 平: "がんの遺伝子治療をアンチセンス治療" 治療. 81. 865-870 (1999)
Taira Maekawa:“癌症的反义基因疗法”治疗。81. 865-870 (1999)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kishi, K., Toba, K., Azegami, T., Tsukada, N., Uesugi, Y., Masuko, M., Niwano, H., Hashimoto, S., Sakaue, M., Furukawa, T., Koike, T., Takahashi, H., Maekawa, T., Abe, T., Aizawa, Y.: "Hematopoietic cytokine-dependent differentiation to eosinophils and ne
Kishi, K.、Toba, K.、Azegami, T.、Tsukada, N.、Uesugi, Y.、Masuko, M.、Niwano, H.、Hashimoto, S.、Sakaue, M.、Furukawa, T.、
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
前川 平: "遺伝子異常をターゲットとしたアンチセンス法" 血液・免疫・腫瘍. 2. 124-130 (1997)
Taira Maekawa:“针对遗传异常的反义方法”血液学/免疫学/肿瘤。2. 124-130 (1997)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kishi,K.et al: "Hematopoielic cytokine-dependent differentiation to easinophils and neutropbils in a newly establisbed..." Exp.Hematol. 26. 135-142 (1998)
Kishi,K.等人:“在新建立的床中,造血细胞因子依赖性分化为嗜酸性粒细胞和中性粒细胞……”Exp.Hematol。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Nishihara, M., Wada, Y., Ogami, K., Ebihara, Y., Ishii, T., Tsuji, K., Ueno, H., Asano, S., Nakahata, T., Maekawa, T.: "A combination of stem cell factor and granulocytecolony-stimulating factor enhances the growth of human progenitor B cells supported by
西原 M.、和田 Y.、大神 K.、海老原 Y.、石井 T.、辻 K.、上野 H.、浅野 S.、中畑 T.、前川 T.:
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 23 条
Eradication of chronic myelogenous leukemia stem cells and abnormal clone with T315I point mutation
-
批准号:21390293
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.07万
-
财政年份:2009
-
负责人:MAEKAWA Taira
-
依托单位:
Molecular therapeutics for imatinib-resistant Ph-positive leukemias with newly developed Bcr-Abl/Lyn tyrosine kinase inhibitor
-
批准号:18390283
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$10.86万
-
财政年份:2006
-
负责人:MAEKAWA Taira
-
依托单位:
Possible mechanism of hematopietic stem cells homing to the bone marrow microenvironment
-
批准号:13671048
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:2001
-
负责人:MAEKAWA Taira
-
依托单位:
Development of Antisense Therapy for Hematological Mailgnancies Targeted Their Rearranged Genes.
-
批准号:11670983
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:1999
-
负责人:MAEKAWA Taira
-
依托单位:
BASIC RESEARCH ON GENE THERAPY FOR HUMAN LEUKEMIAS BY ANTISENSE OLIGODEOXYNUCLEOTIDES
-
批准号:04671531
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.41万
-
财政年份:1992
-
负责人:MAEKAWA Taira
-
依托单位:
海外基金